Allison Smego
( out of 16 reviews )

Allison Smego, MD

Languages spoken: English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Dr. Smego is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Utah. She earned her medical degree from the University of Cincinnati School of Medicine. She completed residency training in Pediatrics at Vanderbilt University and her Pediatric Endocrinology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Smego is board certified in General Pediatrics and board certified in the subspecialty of Pediatric Endocrinology.

Specialties

Board Certification

American Board of Pediatrics (Sub: Pediatric Endocrinology)
American Board of Pediatrics (Pediatrics)
National Board of Medical Examiners

Patient Rating

5.0 /5
( out of 16 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

EXTERNAL SITE

Very good!

PRIMARY CHILDREN'S OUTPATIENT SERVICES

Dr. Smego was very thorough in her questions. She was not rushed and took time to hear everything that might be relevant to [NAME REMOVED]'s case. She clearly explained why he didn't need to be seen for another year. I felt like she took plenty of time, understood all concerns, and made a clear plan of tracking his growth through childhood.

EXTERNAL SITE

Dr. Smego listens to questions and explains things well. She encourages our daughter (now 14 years old) to continue gradually taking responsibility for her own care.

EXTERNAL SITE

Very good!

Dr. Smego is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Utah. She earned her medical degree from the University of Cincinnati School of Medicine. She completed residency training in Pediatrics at Vanderbilt University and her Pediatric Endocrinology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Smego is board certified in General Pediatrics and board certified in the subspecialty of Pediatric Endocrinology.

Board Certification and Academic Information

Academic Departments Pediatrics -Associate Professor (Clinical)
Academic Divisions Diabetes & Endocrinology
Board Certification
American Board of Pediatrics (Sub: Pediatric Endocrinology)
American Board of Pediatrics (Pediatrics)
National Board of Medical Examiners

Education history

Undergraduate Psychology & Pre-Medical Studies - University of Notre Dame B.A.
Professional Medical Medicine - University of Cincinnati College of Medicine M.D.
Residency Pediatrics - Monroe Carell Jr. Children's Hospital at Vanderbilt Resident
Fellowship Pediatric Endocrinology - Cincinnati Children's Hospital Medical Center Fellow
Fellowship Pediatrics Endocrinology - Department of Pediatrics, Division of Endocrinology, Cincinnati Children's Hospital Medical Center Chief Fellow

Selected Publications

Journal Article

  1. Smego AR, Backeljauw P, Gutmark-Little I (2016). Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy. J Clin Endocrinol Metab, 101(5), 2084-8.
  2. Smego A, Woo JG, Klein J, Suh C, Bansal D, Bliss S, Daniels SR, Bolling C, Crimmins NA (2017). High Body Mass Index in Infancy May Predict Severe Obesity in Early Childhood. J Pediatr, 183, 87-93.e1.
  3. Smego A, Lawson S, Courter JD, Warden D, Corathers (2018). Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes. Hospital pediatrics, 8(5), 288-292.
  4. Lawson S, Redel JM, Smego A, Gulla M, Schoettker PJ, Jolly M, Mostajabi F, Hornung (2020). Assessment of a Day Hospital Management Program for Children With Type 1 Diabetes. JAMA network open, 3(3), e200347.
  5. Miyazaki B, Ebekozien O, Rompicherla S, Ohmer A, Guttman-Bauman I, Mucci A, Guarneri A, Raman V, Smego A, Dickinson J (2023). Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019. Diabetes spectrum, 36(4), 398-402.
  6. Ospelt E, Hardison H, Rioles N, Noor N, Weinstock RS, Cossen K, Mathias P, Smego A, Mathioudakis N, Ebekozien O, T1D Exchange Quality Improvement Collaborativ (2024). Understanding Providers' Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study. Clinical diabetes, 42(1), 17-26.
  7. Coletti ML, Keene JC, Smego AR, Young MP, Ostrander (2025). Developmental, Endocrine, and Ophthalmologic Outcomes in Children Prenatally Diagnosed With Midline Brain Malformations. Pediatric neurology, 167, 82-88.

Abstract

  1. Morales Moreno J, Smego A, Stipleman (2023). Risk-based Quality Improvement for Type 2 Diabetes Screening in Primary Care. American Pediatric Association, Region 9 & 10 Meeting. Monterey, CA. .
  2. Meder M*, Jelley H, Gallenberger M, Murray M, Zhang Y, Li H, Smego (2022). Use of Basal-Bolus Subcutaneous Insulin in the Initial Management of Mild to Moderate Diabetic Ketoacidosis is Safe in Type 1 Diabetes. . 95(Suppl 1), 76-77.
  3. Meder M, Jelley H, Smego A, Raman V, Raleigh (2022). Addison's Disease Presenting with Recurrent Pericardial Effusion and Cardiac Tamponade. 95(Suppl 1), 17-18.
  4. Jelley H, Meder M, Murray M, Raman V, Raleigh Z, Foster C, Smego A, Kocolas I, Al-Hamad (2021). Infantile hypophosphatasia as a cause of severe hypotonia and hypercalcemia. 94(Suppl 2), 14-15.
  5. Jelley H, Mistry S, Meder M, Smego A, Raman (2023). Health Inequities in the Use of Diabetes Technology Among Racial/Ethnic Minority Pediatric Patients with Type 1 Diabetes. Presented Pediatric Endocrine Society 2023. 96(S3), 122-128.
  6. Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell (2023). Possible Insulin Allergy Presenting with Anaphylaxis. Presented at Pediatric Endocrine Society 2023. 96(S3), 122-128.
  7. Coletti M, Keene J, Smego A, Young M, Ostrander (2023). Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Poster presentation at Child Neurology Society in Fall 2023. . 94(S31), S70.
  8. Ospelt E, Hardison H, Rioles N, Noor N, Crossen S, Smego A, Aleppo G, Friedman J, Eng D, Sullivan C, Majidi S, Lorincz I, Ebekozien (2023). Provider Perceptions of Barriers and Benefits to Type 1 Diabetes Autoantibody Testing Among Patients and Relatives. Poster Presentation at the 83rd ADA Scientific Sessions. June 2023. . 72(S1), 1290.
  9. Smego A, Asfour F, Sirstins J, Loizos C, Counter M, Whitaker B, Bjerregaard S, Wadhwa T, Gubler L, Raman (2023). Increasing Pump Therapy Adoption in Patients with Type 1 Diabetes. 15(S1), 28-29.
  10. Coletti M, Keene J, Smego A, Young M, Ostrander (2024). Endocrine, Ophthalmic and Developmental Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Presented at International Newborn Brain Conference Feb 2024 by lead author. . 17(3), S293-S295.
  11. Demeterco-Berggren, C, Jacobsen, L, Guttman-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Choudhary, A, Wong, J, Ebekozien, O (2024). Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among centers participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Poster Presentation at the 84th ADA Scientific Sessions. June 2024. . 73(S1), 1293-P.
  12. Canter R*, Raman V, Sund S, Sirstins J, Edwards A, Counter M, Whitaker B, Wadhwa T, Couldwell M, Smego (2024). Increasing Scheduling of Adult Diabetes Care Prior to Graduation from Pediatric Diabetes Care for Patients with Type 1 Diabetes. 16(S1), 32.
  13. Smego A, Solorzano D*, Weber J*, Sirstins J, Chery Zoey, Raman (2026). Improving Adherence to Screening Guidelines for Eye Examination in Youth with Diabetes. 18, 34-35.

Video/Film/CD/Web/Podcast

  1. Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego (2021). Diagnosis and Treatment of Pediatric Type 1 Diabetes. Care Process Model. Intermountain Healthcare.
  2. Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego (2021). Management and Treatment of Pediatric Type 2 Diabetes. Care Process Model. Intermountain Healthcare. .

News & Podcasts

News